Back to Results
First PageMeta Content
Hematology / Clinical research / Design of experiments / Moroctocog alfa / Factor VII / Clinical trial / Desmopressin / Von Willebrand disease / Drotrecogin alfa / Medicine / Haemophilia / Health


Summary Basis for Regulatory Action Date: [removed]From: Irwin M. Feuerstein, M.D., M.S., M.B.A., Chair of the BLA BLA/STN#: [removed]Applicant Name: Pfizer Incorporated / Wyeth Biopharma Division of Wyeth Pharmaceu
Add to Reading List

Open Document

File Size: 582,59 KB

Share Result on Facebook
UPDATE